Archived news features

  • A number of stipends and bursaries are available to help consumers and other attendees based in developing countries to attend Cochrane Colloquium Santiago 2019.This 26th annual flagship event will take place at CasaPiedra in the vibrant city of Santiago, Chile, 22-25 October 2019.Stipends and bursaries represent funding you can apply...
    May 10 2019
  • Tuberculosis has been killing people for centuries and the prospect of a vaccine to stop this has eluded scientists for years. In 2012, the Bill and Melinda Gates Foundation invested an initial USD 220 million in tuberculosis vaccine development through AERAS; one of the candidate vaccines that advanced, known as MVA85A, was developed as an add-on...
    May 1 2019
  • This year’s Cochrane UK & Cochrane Ireland Symposium took place at the Saïd Business School, Oxford. The theme of the symposium was “Inspiring innovation – ensuring quality”, and CIDG members, Marty Richardson (Statistician) and Vittoria Lutje (Information Specialist), joined Cochrane colleagues from all over the UK and Ireland at the event....
    April 3 2019
  • Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 4, 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 30 April).1 New ReviewKashangura  R, Jullien  S, Garner  P, Johnson  S. MVA85A vaccine to enhance BCG for preventing...
    April 2 2019
  • Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. When it is detected early and effectively treated, TB is largely curable, but in 2017, around 1.6 million people died of tuberculosis, including 300,000 people living with HIV.[1] Early diagnosis of TB, including universal drug...
    March 29 2019
  • The Cochrane Infectious Diseases Group  (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis. Ahead of World TB Day, this week welcomes the publication of a Special Collection on the Cochrane Library  that tracks the development of exciting new diagnostic...
    March 29 2019
  • Plain language summaryLinezolid for managing people with drug‐resistant tuberculosisWhat is drug‐resistant tuberculosis, and how might linezolid work?Tuberculosis is caused by infection with Mycobacterium tuberculosis bacteria. When there are symptoms or signs of illness, this is called active tuberculosis. An estimated one‐third of the...
    March 20 2019
  • LSTM's Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane's premier groups, with over 150 Cochrane...
    March 19 2019
  •  In this report, we meet Anel Schoonees, who works with the CIDG editorial base as an Information Specialist with a special focus on the HIV portfolio. Could you describe where you currently work and what you do there? Since 2009, I have been working at Stellenbosch University in Cape Town, South Africa. I am a researcher here at the...
    March 8 2019
  • Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 2, 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 28 February).1 New ProtocolChoi  L, Johnson  S, Cunningham  J, Takwoingi  Y. Rapid diagnostic tests for Plasmodium vivax malaria in endemic...
    March 8 2019

Pages

Subscribe to Our news